Spinal cord injury cervical

2 trials 2 recruiting MedDRA PT
2 Registered trials
2 Recruiting
2 Unique sponsors
2 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
A Gastroenterology (ATC A) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase I/II: 1 Phase I: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase I/II

1 trial
  • Sinfatin S.L. Commercial
    RIMONABANT
    2025-524279-22-00 1 country 2026 n=8
    Recruiting

Phase I

1 trial
  • NovaGo Therapeutics AG Commercial
    NG004
    2024-514303-34-00 1 country 2024 n=19
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
NovaGo Therapeutics AG Commercial 1 Phase I 1
Sinfatin S.L. Commercial 1 Phase I/II 1
New trials by year
2024
1
2026
1
← All indication landscapes